The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin’s lymphoma
- 1 June 1999
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 44 (3) , 563-568
- https://doi.org/10.1016/s0360-3016(99)00051-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.Journal of Clinical Oncology, 1996
- Significance of tumor size and radiation dose to local control in Stage I–III diffuse large cell lymphoma treated with CHOP-Bleo and radiationInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?Blood, 1994
- Retrospective analysis of stage I and II indolent lymphomas at the National Cancer InstituteInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Prognostic factors in nodular lymphomas: A multivariate analysis based on the Princess Margaret Hospital experienceInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and IICancer, 1983
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Follicular lymphoma.A re-evaluation of its position in the scheme of malignant lymphoma based on a survey of 253 casesCancer, 1956